These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27932517)

  • 1. Allergin-1 inhibits TLR2-mediated mast cell activation and suppresses dermatitis.
    Tsurusaki S; Tahara-Hanaoka S; Shibagaki S; Miyake S; Imai M; Shibayama S; Kubo M; Shibuya A
    Int Immunol; 2016 Dec; 28(12):605-609. PubMed ID: 27932517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergin-1 on mast cells suppresses house dust mite-induced airway hyperresponsiveness in mice.
    Hitomi K; Tahara-Hanaoka S; Miki H; Iwata K; Shibayama S; Kubo M; Shibuya A
    Int Immunol; 2018 Aug; 30(9):429-434. PubMed ID: 30169732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective suppression of oral allergen-induced anaphylaxis by Allergin-1 on basophils in mice.
    Lin YH; Tahara-Hanaoka S; Nagai K; Yoshikawa S; Kubo M; Shibayama S; Karasuyama H; Shibuya A
    Int Immunol; 2020 Mar; 32(3):213-219. PubMed ID: 31793637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions.
    Hitomi K; Tahara-Hanaoka S; Someya S; Fujiki A; Tada H; Sugiyama T; Shibayama S; Shibuya K; Shibuya A
    Nat Immunol; 2010 Jul; 11(7):601-7. PubMed ID: 20526344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of Allergin-1 on human primary mast cells.
    Nagai K; Tahara-Hanaoka S; Morishima Y; Tokunaga T; Imoto Y; Noguchi E; Kanemaru K; Imai M; Shibayama S; Hizawa N; Fujieda S; Yamagata K; Shibuya A
    PLoS One; 2013; 8(10):e76160. PubMed ID: 24116093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
    Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
    J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inhibitory immunoreceptor, Allergin-1, suppresses FITC-induced type 2 contact hypersensitivity.
    Almeida MS; Shibagaki S; Tahara-Hanaoka S; Shibayama S; Shibuya A
    Biochem Biophys Res Commun; 2021 Nov; 579():146-152. PubMed ID: 34601199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis.
    Selander C; Engblom C; Nilsson G; Scheynius A; Andersson CL
    J Immunol; 2009 Apr; 182(7):4208-16. PubMed ID: 19299719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergy inhibitory receptor-1 inhibits autoantibody production via upregulation of apoptotic debris clearance by macrophages.
    Iizuka A; Segawa S; Kondo Y; Kaneko S; Yokosawa M; Furuyama K; Miki H; Tahara-Hanaoka S; Shibuya A; Tsuboi H; Goto D; Matsumoto I; Shibayama S; Sumida T
    Int J Rheum Dis; 2018 Dec; 21(12):2071-2078. PubMed ID: 30556363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells.
    Kasakura K; Takahashi K; Aizawa T; Hosono A; Kaminogawa S
    Int Arch Allergy Immunol; 2009; 150(4):359-69. PubMed ID: 19571568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness.
    Sawaguchi M; Tanaka S; Nakatani Y; Harada Y; Mukai K; Matsunaga Y; Ishiwata K; Oboki K; Kambayashi T; Watanabe N; Karasuyama H; Nakae S; Inoue H; Kubo M
    J Immunol; 2012 Feb; 188(4):1809-18. PubMed ID: 22250079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation.
    Shiba E; Izawa K; Kaitani A; Isobe M; Maehara A; Uchida K; Maeda K; Nakano N; Ogawa H; Okumura K; Kitamura T; Shimizu T; Kitaura J
    J Biol Chem; 2017 Feb; 292(7):2924-2932. PubMed ID: 28073916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection.
    Carlos D; Frantz FG; Souza-Júnior DA; Jamur MC; Oliver C; Ramos SG; Quesniaux VF; Ryffel B; Silva CL; Bozza MT; Faccioli LH
    Microbes Infect; 2009; 11(8-9):770-8. PubMed ID: 19442756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis.
    Kurashima Y; Amiya T; Fujisawa K; Shibata N; Suzuki Y; Kogure Y; Hashimoto E; Otsuka A; Kabashima K; Sato S; Sato T; Kubo M; Akira S; Miyake K; Kunisawa J; Kiyono H
    Immunity; 2014 Apr; 40(4):530-41. PubMed ID: 24726878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gp49B1 suppresses stem cell factor-induced mast cell activation-secretion and attendant inflammation in vivo.
    Feldweg AM; Friend DS; Zhou JS; Kanaoka Y; Daheshia M; Li L; Austen KF; Katz HR
    Eur J Immunol; 2003 Aug; 33(8):2262-8. PubMed ID: 12884301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential isoform expression of Allergin-1 during acute and chronic inflammation.
    Geerdink RJ; Pascoal Ramos MI; van den Hoogen LL; Radstake TRDJ; Shibayama S; Shibuya A; Bont L; Meyaard L
    Immun Inflamm Dis; 2022 Dec; 10(12):e739. PubMed ID: 36444625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2.
    Hao Y; Peng B; Che D; Zheng Y; Kong S; Liu R; Shi J; Han H; Wang J; Cao J; Zhang Y; Gao J; He L; Geng S
    Int Immunopharmacol; 2020 Apr; 81():106258. PubMed ID: 32044660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis.
    Mullaly SC; Kubes P
    Eur J Immunol; 2007 Jan; 37(1):224-34. PubMed ID: 17154261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth.
    Oldford SA; Haidl ID; Howatt MA; Leiva CA; Johnston B; Marshall JS
    J Immunol; 2010 Dec; 185(11):7067-76. PubMed ID: 21041732
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.